New baby formula study aims for better growth and digestion

NCT ID NCT07513506

Not yet recruiting Disease control Sponsor: Mead Johnson Nutrition Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study compares a new extensively hydrolyzed casein formula (not yet FDA-approved) to a currently available one in 214 healthy infants aged 10-14 days. Researchers will measure weight gain, length, head size, stool patterns, and tolerance (spit-up, fussiness, gas). The goal is to see if the new formula supports normal growth and is well-tolerated.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: extensively hydrolyzed casein-based infant formula
What this could lead to: If successful, this could provide a new option for infants who need a hypoallergenic formula, supporting normal growth and digestion.
What could go wrong: This is an early-stage study comparing two formulas, not a treatment for a disease. Results may not show significant differences, and individual infant tolerance can vary.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GROWTH are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

GROWTH

Contacts and locations

Locations

AMR

Syracuse, Utah, 84075, United States
AVIATI Healthcare & Clinical Research

Memphis, Tennessee, 38115, United States
Alabama Clinical Therapeutics

Birmingham, Alabama, 35235, United States
Alabama Clinical Therapeutics

Birmingham, Alabama, 35235, United States
Childrens Clinic of Jonesboro

Jonesboro, Arkansas, 72401, United States
Hope Research Network

Virginia Gardens, Florida, 33166, United States
InnovoResearch

Wilmington, North Carolina, 28405, United States
Mid Valley Research Inc.

Moline, Illinois, 61265, United States
NeutraLife Science

Richmond, Texas, 77469, United States
SPRIM

Harbor Beach, Florida, 32937, United States
Springs Medical Research

Owensboro, Kentucky, 42303, United States
Symphony Research

Jacksonville, Florida, 32224, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.